Invrix.com

Financial Statement Analysis Industry Analysis News Analysis

Login Register

Analysis Tools

Financial Trends Company Comparisons Profitability Radar Industry Leaderboard

User

Login Register

Home
/
Biotechnology: Pharmaceutical Preparations
/
INZY

Inozyme Pharma(Inzy) Financials: Compared To Industry Average, Plus Other Key Ratios

Report Profitability Growth Liquidity Solvency Valuation

Valuation Trend (Last 5 Years)

Top 20 by ratio

DRRX - DURECT
TAK - Takeda Pharmaceutical ( )
GLYC - GlycoMimetics
CDTTW - Conduit Pharmaceuticals
GDTC - CytoMed Therapeutics Ordinary Shares
GANX - Gain Therapeutics
TLX - Telix Pharmaceuticals
DSGN - Design Therapeutics
IONS - Ionis Pharmaceuticals
IBO - Impact BioMedical
NVO - Novo Nordisk A/S
VRTX - Vertex Pharmaceuticals
CSCI - COSCIENS Biopharma
SNDX - Syndax Pharmaceuticals
SONN - Sonnet BioTherapeutics
ITRM - Iterum Therapeutics plc Ordinary Share
NTHI - NeOnc Technologies
TELO - Telomir Pharmaceuticals
ABBV - AbbVie
EPIX - ESSA Pharma

© 2025 Invrix. All rights reserved.

About Us Contact Privacy Policy Terms of Service